Predict your next investment

Private Equity
hmcapital.com

See what CB Insights has to offer

Investments

12

Portfolio Exits

6

Funds

9

Service Providers

2

About HM Capital

The firm focuses on building a diverse portfolio of companies which have the potential to increase in value through geographic and product line expansion, strategic acquisitions of complementary businesses, and internal growth strategies. It is particularly interested in opportunities to buy companies in fragmented, but consolidating industries, and to build on these platforms through add-on acquisitions.

HM Capital Headquarter Location

200 Crescent Court Suite 1600

Dallas, Texas, 75201,

United States

(214)740-7300

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest HM Capital News

Sale of Advanced H2O, Inc. of Seattle, WA

Sep 16, 2020

Sale of Advanced H2O, Inc. of Seattle, WA   Chicago, IL – LaSalle Capital Group, L.P. (“LaSalle Capital”) announced the sale of its platform company, Advanced H2O, LLC, to HM Capital Partners, LLC of Dallas, TX. Advanced H2O, based in Mercer Island, WA, is a leading supplier of private label bottled water and non-carbonated beverages to large retail customers in the western U.S. and Canada. In June 2005, LaSalle Capital and its investment partner Merit Capital Partners, both of Chicago, IL, acquired the Company through a leveraged recapitalization in partnership with Bob Abramowitz, the Company’s founder and CEO. Bob and his management team will continue to lead the Company and will retain partial ownership of the Company after the sale to HM Capital. Advanced H2O has experienced tremendous growth since its inception in 1998. During the course of LaSalle Capital’s ownership, the company tripled its production capacity, opened a state-of-the art facility in Stockton, CA and expanded its business geographically into Northern California and Canada. In announcing the sale, Jeff Walters, Partner at LaSalle Capital stated, “It has been a pleasure to work with Bob Abramowitz and his fine management team and to have achieved such a successful exit.” Bob Abramowitz, CEO of Advanced H2O added, “LaSalle Capital helped us transform our business from a regional bottled water company into a vertically integrated, nationally recognized player,” adding, “we hope to continue building our platform with our new partners at HM Capital.” © 2020, LaSalle Capital. All Rights Reserved.Find us on

HM Capital Investments

12 Investments

HM Capital has made 12 investments. Their latest investment was in Yeasen as part of their Series B - II on August 8, 2021.

CBI Logo

HM Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/26/2021

Series B - II

Yeasen

$46M

Yes

CITIC Capital, Haiwang Capital, Hongkou Kangrui Investment, and Huasai Fund

4

4/19/2021

Series A

Porton Biologics

$61.45M

Yes

GL Ventures, Huashan Capital, Momentum Venture Capital, and SDIC Capital

2

1/5/2021

Series F

Sagimet Biosciences

$80M

Yes

5AM Ventures, ACG Private Equity, Ascletis Pharma, Invus Group, Kleiner Perkins Caufield & Byers, New Enterprise Associates, PFM Asset Management, Rock Springs Capital, Undisclosed Investors, and Westlake Village BioPartners

5

9/9/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

6/16/2009

Private Equity

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/26/2021

4/19/2021

1/5/2021

9/9/2020

6/16/2009

Round

Series B - II

Series A

Series F

Series B

Private Equity

Company

Yeasen

Porton Biologics

Sagimet Biosciences

Subscribe to see more

Subscribe to see more

Amount

$46M

$61.45M

$80M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

CITIC Capital, Haiwang Capital, Hongkou Kangrui Investment, and Huasai Fund

GL Ventures, Huashan Capital, Momentum Venture Capital, and SDIC Capital

5AM Ventures, ACG Private Equity, Ascletis Pharma, Invus Group, Kleiner Perkins Caufield & Byers, New Enterprise Associates, PFM Asset Management, Rock Springs Capital, Undisclosed Investors, and Westlake Village BioPartners

Sources

4

2

5

10

10

HM Capital Portfolio Exits

6 Portfolio Exits

HM Capital has 6 portfolio exits. Their latest portfolio exit was OncoImmune on November 23, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/23/2020

Acquired

$991

Merck & Co.

4

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

11/23/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Exit

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

Acquirer

Merck & Co.

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

4

10

10

10

10

HM Capital Acquisitions

3 Acquisitions

HM Capital acquired 3 companies. Their latest acquisition was SunTerra Oil & Gas on March 09, 2009.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/9/2009

Leveraged Buyout

Leveraged Buyout

1

4/24/2008

Subscribe to see more

$99M

Subscribe to see more

10

1/20/1998

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/9/2009

4/24/2008

1/20/1998

Investment Stage

Leveraged Buyout

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

Total Funding

$99M

$99M

Note

Leveraged Buyout

Subscribe to see more

Subscribe to see more

Sources

1

10

10

HM Capital Fund History

9 Fund Histories

HM Capital has 9 funds, including Hicks Muse Equity Fund LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/14/2021

Hicks Muse Equity Fund LP

$310M

2

5/30/2008

HM Capital 2006 Sector Performance Fund LP

Subscribe to see more

$99M

10

6/1/2001

Hicks Muse Tate & Furst Equity Fund V LP

Subscribe to see more

$99M

10

12/1/2000

Hicks Muse Tate & Furst Latin Am. Fund II LP

Subscribe to see more

$99M

10

12/31/1999

Hicks Muse Tate & Furst Europe Fund LP

Subscribe to see more

$99M

10

Closing Date

1/14/2021

5/30/2008

6/1/2001

12/1/2000

12/31/1999

Fund

Hicks Muse Equity Fund LP

HM Capital 2006 Sector Performance Fund LP

Hicks Muse Tate & Furst Equity Fund V LP

Hicks Muse Tate & Furst Latin Am. Fund II LP

Hicks Muse Tate & Furst Europe Fund LP

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Amount

$310M

$99M

$99M

$99M

$99M

Sources

2

10

10

10

10

HM Capital Service Providers

2 Service Providers

HM Capital has 2 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Associated Rounds

Subscribe to see more

Provider Type

Counsel

Subscribe to see more

Service Type

Subscribe to see more

Partnership data by VentureSource

HM Capital Team

3 Team Members

HM Capital has 3 team members, including current Founding Partner, Jack D Furst.

Name

Work History

Title

Status

Jack D Furst

Founding Partner

Current

John R. Muse

Kainos Capital

Chief Executive Officer

Former

Darron Ash

Chief Financial Officer

Former

Name

Jack D Furst

John R. Muse

Darron Ash

Work History

Kainos Capital

Title

Founding Partner

Chief Executive Officer

Chief Financial Officer

Status

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.